ETF BIGT L&G PHARMA BREAKTHROUGH UCITS ETF - USD
Add to a list
To use this feature you must be a member
Log inSign up

News L&G Pharma Breakthrough UCITS ETF - USD

ETF

BIGT

IE00BF0H7608

Market Closed - London S.E.
Other stock markets
 09:05:20 26/06/2024 pm IST 		5-day change 1st Jan Change
9.902 USD +0.06% Intraday chart for L&G Pharma Breakthrough UCITS ETF - USD +4.31% -6.02%
2018 ETFS Pharma Breakthrough GO UCITS ETF has Changed its Name to L&G Pharma Breakthrough UCITS ETF CI

All the latest ETF news

US value stocks offer opportunities for bargain-hunters, BofA's Subramanian says RE
GoodRx Launches New "Prescription Cost Tracker" to Spotlight Key Factors Driving Out-Of-Pocket Medication Costs in the U.S CI
Cryptoverse: Trump drubs Biden in meme coins RE
SPDR Dow Jones Industrial Average ETF Trust Reports Earnings Results for the Half Year Ended April 30, 2024 CI
VanEck sets 0.20% fee for proposed spot ethereum ETF RE
US equity funds witness outflows for second successive week RE
Global equity funds see outflows for second week in a row RE
Schwab Fundamental U.S. Broad Market Index ETF will Change its Name to Schwab Fundamental U.S. Broad Market ETF CI
Schwab Fundamental Emerging Markets Large Company Index ETF will Change its Name to Schwab Fundamental Emerging Markets Equity ETF CI
Schwab Fundamental International Small Company Index ETF will Change its Name to Schwab Fundamental International Small Equity ETF CI
Schwab Fundamental International Large Company Index ETF will Change its Name to Schwab Fundamental International Equity ETF CI
Schwab Fundamental U.S. Small Company Index ETF will Change its Name to Schwab Fundamental U.S. Small Company ETF CI
Schwab Fundamental U.S. Large Company Index ETF will Change its Name to Schwab Fundamental U.S. Large Company ETF CI
Biden-era policy against hospital web trackers unlawful, judge rules RE
US CFTC probing Jump Trading's involvement in crypto, Fortune reports RE
More news

Description

IE00BF0H7608
Total Expense Ratio 0.49%
Asset Class
Sector
Size
Currency
Provider
Underlying Solactive Pharma Breakthrough Value NTR Index - USD

Features and characteristics

Jurisdiction
Replication Method
Replication Model
Date of creation
23/01/2018
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 31/05/2024 )

AuM (EUR) 17 M€
AuM 1M 17 M€
AuM 3 months 21 M€
AuM 6 months 28 M€
AuM 12 months 56 M€
  1. Stock Market
  2. ETF
  3. BIGT ETF
  4. News L&G Pharma Breakthrough UCITS ETF - USD